JP Morgan Call 120 iShares Nasdaq.../ DE000JB4UXS1 /
2024-05-20 9:06:53 AM | Chg.- | Bid10:00:36 PM | Ask10:00:36 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.60EUR | - | - Bid Size: - |
- Ask Size: - |
- | 120.00 - | 2024-06-21 | Call |
GlobeNewswire
05-23
Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05-21
Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data ...
Newsfile Corp
05-15
Maxwell Biosciences CEO J. Scotch McClure Named Top 25 Executive in Biotechnology
GlobeNewswire
05-14
UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates
GlobeNewswire
05-09
Curia and Carterra Partner on Biologics Symposium to Further Biotechnology Research in the Pacific N...
GlobeNewswire
05-08
Sana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates
GlobeNewswire
05-08
Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cance...
GlobeNewswire
05-08
LIXTE Biotechnology Co-Sponsoring International Scientific Conference on “Therapeutic Over-Activatio...
GlobeNewswire
04-25
UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting
GlobeNewswire
04-23
UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME
GlobeNewswire
04-16
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Dir...
GlobeNewswire
04-15
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business U...
GlobeNewswire
04-15
Regeneron Ventures Launches with $500 Million Commitment to Fuel Promising Biotechnology Innovation
GlobeNewswire
04-11
Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
GlobeNewswire
04-09
Hemp, Inc. Welcomes USDA Approval of GMO Hemp Strain – A Step Forward in Cannabis Biotechnology
GlobeNewswire
03-22
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors